ArticleThe Lancet. Oncology2020
Fulvestrant plus capivasertib for metastatic breast cancer - Authors' reply.
Robert H Jones et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2020
Robert H Jones et al.PubMed ↗Publisher ↗
No numbers read from the abstract.